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Abstract 
There is a great need to identify predictors of treatment response, and the analysis of defense 
mechanisms is a promising approach. Defensive functioning may influence psychotherapy 
outcome in two ways: First, when it is generally higher or lower for some patients relative to 
others and second, as it shifts in individual patients over time. The present study examined 
both within- and between patient effects of defenses using hierarchical linear modeling. 
Forty-seven patients diagnosed with depression, anxiety, or adjustment disorders received 
25±3 sessions of integrative cognitive-behavioral therapy in a university outpatient clinic. The 
Defense Mechanism Rating Scale (DMRS) was used to assess defenses in the 1st, 8th, 16th, and 
24th session and relate them to symptom severity of depression and anxiety. A higher number 
of adaptive defense mechanisms was associated with less severe depressive symptoms during 
treatment while a higher number of immature defenses was related to more severe depressive 
and anxiety symptoms. An increase in adaptive and a decrease in immature defenses over the 
course of treatment predicted symptom reduction of depression whereas a decrease in neurotic 
and immature defenses was associated with reductions in anxiety symptoms. Our results 
empirically support defensive functioning as a mechanism of change in psychotherapy. 
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Introduction 
There is a great need to understand the mechanisms of change at work in 
psychotherapy (Crits-Christoph, Gibbons, & Mukherjee, 2013) and the analysis of defense 
mechanisms is a promising approach. Defenses are defined as “automatic psychological 
processes which protect the individual from anxiety and unnecessary awareness of internal 
and external dangers and stressors” (APA, 2000). A three-level hierarchical classification of 
defenses was introduced: adaptive, neurotic, and maladaptive (Vaillant, 1971). Adaptive 
defenses typically maximize awareness of internal states and result in both, positive outcome 
and the most effective psychological protection, whereas maladaptive defenses act to restrict 
or alter awareness of internal states and conflicts, thus limiting positive outcome (Kneepkens 
& Oakley, 1996). Overall defensive functioning (ODF) represents a summary score and 
reflects the average level of adaptation.  
Defensive functioning may influence psychotherapy outcome in at least two ways: 
First, when generally higher or lower for some patients relative to others (between-patient 
differences) and second, it may also promote improvement as it shifts in individual patients 
over time (within-patient changes). So far, research has focused on between-patient effects of 
defensive functioning on treatment outcome using defenses as measured at intake to predict 
outcome at the symptomatic level: lower (more maladaptive) scores in defensive functioning 
were significantly related to the presence and severity of depressive (e.g., DeFife & 
Hilsenroth, 2005; Hoglend & Perry, 1998) and anxiety symptoms (Heldt, Manfro, & Kipper, 
2003). However, such analyses do not necessarily mean that improving defensive functioning 
with a given patient will improve therapy outcome (within-patient effects; Falkenström, 
Finkel, Sandell, Rubel, & Holmqvist, 2017).  
So far, only a limited number of studies addressed defenses using repeated measures to 
observe changes in defense style and its predictive value for therapy outcome (e.g. Hill et al., 
2015; Johansen, Krebs, Svartberg, Stiles, & Holen, 2011; Kramer, deRoten, Perry & 
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Despland, 2012; Kramer, Despland, Michel, Drapeau, & deRoten, 2010; Perry & Bond, 
2012). Overall defensive functioning (ODF) has been shown to improve from pre to post 
therapy in patients with depression and anxiety disorders (e.g., Drapeau, deRoten, Perry, & 
Despland, 2003; Kramer et al., 2012). In studies with primarily depressed patients, adaptive 
defenses increased, and maladaptive defenses decreased while neurotic defenses did not 
change meaningfully (Akkermann, Lewin, & Carr, 1999; Bond & Perry, 2004; Kneepkens & 
Oakley, 1996; Perry & Bond, 2009). In studies with mostly anxious patients, both neurotic 
(Kipper et al., 2005) and maladaptive defenses (Heldt et al., 2007; Hersoug, Bøgwald, & 
Høglend, 2005) decreased over the course of treatment with no significant change in the 
adaptive defense category. Change in ODF has repeatedly been presented as a significant 
predictor of therapy outcome at the symptomatic level (e.g., Bond & Perry, 2004; Heldt et al., 
2007; Kramer, de Roten, Perry, & Despland, 2013). 
Taken together, findings suggest that both within- and between patient effects of 
defensive functioning predict psychotherapy outcome. However, to date they were never 
analyzed within the same model, thereby controlling for the effect of the respective other. 
Further, since previous studies assessed defenses only twice, usually at baseline and treatment 
termination, longitudinal analyses were methodologically not feasible (Singer & Willet, 
2003). Thus, these studies limited their analyses to the estimation of the fixed effects defenses 
exhibited on therapy outcome, assuming that effects were homogenous among patients while 
not accounting for the nested structure of the data (i.e., repeated measures nested within 
patients; Gómez Penedo, Muiños, Hirsch, & Roussos, 2019). Also, it could not be determined 
if defense change preceded symptom change or the other way around. 
Building on and extending previous research, the present study aims to analyze the 
effects of defenses on outcome using longitudinal models (i.e., addressing the nestedness of 
the data) and to disaggregate within- and between-patient effects of this predictor. To our 
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knowledge, this is the first study to apply such methods to defenses, making it a useful 
addition to previous research in the area. The following four hypotheses were tested: 
1. ODF, adaptive defenses, and maladaptive defenses during treatment will display significant 
between-patient effects on depressive symptoms. More specifically, a higher frequency of 
adaptive defenses and a lower frequency of maladaptive defenses will be associated with 
lower severity of depressive symptoms. 
2. ODF, neurotic defenses, and maladaptive defenses during treatment will exhibit significant 
between-patient effects on anxiety symptoms. A lower frequency of neurotic and maladaptive 
defenses will be associated with a lower severity of anxiety symptoms. 
3. Change in ODF and in the frequency of adaptive and maladaptive defenses will show 
significant within-patient effects on change of depressive symptoms. An increase in adaptive 
defenses and a decrease in maladaptive defenses will be associated with a reduction in 
depressive symptoms. 
4. Change in ODF and in the frequency of neurotic and maladaptive defenses will result in 
significant within-patient effects on change of anxiety symptoms. A decrease in neurotic and 
maladaptive defenses will be associated with a reduction in anxiety symptoms. 
Methods 
Participants 
The sample consisted of 47 consecutively recruited patients from a randomized 
controlled trial who all received 25±3 sessions of integrative cognitive-behavioral therapy in a 
university outpatient clinic. Of 47 patients, 29 (62%) were female with a mean age of 32.09 
years (SD = 10.5). Twenty-two patients (44%) met diagnostic criteria for a principal diagnosis 
of unipolar depression (ICD; F32), 17 patients (34%) for an anxiety disorder (ICD; F40, F41) 
and eight (16%) for adjustment disorder (ICD; F43.2). Previous research failed to identify 
variables that independently differentiated adjustment disorder from depressive episodes 
(Casey et al., 2006), which is why patients diagnosed with adjustment disorder were included 
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in our study. Research diagnoses were established by trained staff with the Structured Clinical 
Interview for DSM-IV-R (First, Spitzer, Gibbon, & Williams, 2004). Exclusion criteria 
included substance dependence within the last six months, current risk of suicide, immediate 
risk of self-harm or harm to others, and the presence of a likely organic cause for the mental 
disorder. Subjects simultaneously receiving other psychological treatments were also 
excluded. Treatment was provided by 18 (69.23%) female and eight (30.76%) male 
psychotherapists with a mean age of 34.49 years (SD = 8.63). The trial was approved by the 
Cantonal Ethics Committee (KEK BE 168/15), and all patients gave written informed consent 
for their therapy sessions to be video-recorded and the data being used in the context of the 
trial. 
Study design 
The design included the assessment of defensive functioning (ODF, adaptive, 
neurotic, and immature defenses) as well as the severity of depression and anxiety symptoms 
as both, within and between subject factors (see Babl et al., 2016 for the study design of the 
RCT). 
Material 
Defense Mechanism Rating Scale. The Defense Mechanism Rating Scale (DMRS; 5th 
edition; Perry, 1990), is an observer-rated manual for the identification of 30 individual 
defense mechanisms in session transcripts of psychotherapy. The manual comprises a 
definition of each defense mechanism, a description of the intra-psychic function and a list of 
similar mechanisms and indications of how to distinguish them. The 30 defense mechanisms 
are arranged hierarchically, divided into seven levels. The higher the level on which a defense 
mechanism is located, the greater the score assigned to it. With adaptive defense mechanisms 
positive and negative aspects of reality are seen together with minimal distortion, minimal 
avoidance of stressors and maximal gratification of wishes. Adaptive defenses receive seven 
points, since they belong to level seven. Neurotic defenses, as located on levels five and six, 
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lead to mild distortion of reality, some avoidance of stressors, some gratification and some 
symptom formation. Maladaptive defenses comprise levels one to four. Here, positive and 
negative aspects of reality are kept separate with a clear distortion, stressors are simplified to 
either internal or external and small stressors receive big meaning. All defense mechanisms 
are evaluated with a score corresponding to their level. Based on the scoring, the overall 
defensive functioning and defense category scores can be calculated.  
Six Master-level psychology students underwent six months of intensive rater training 
in the DMRS. Over the course of the rater training, nine session transcripts with 21 to 30 
pages each (M = 26) were coded, and eleven consensus meetings of two to six hours each 
were held, amounting to around 34 hours. Raters then transcribed and rated a total of 192 
therapy sessions in a secured and designated rating room at the University, between August 
2017 and August 2018. For each patient, the 1st, 8th, 16th and 24th sessions were transcribed 
and rated for defense mechanisms to reflect the course of the treatment. In case of technical 
malfunctioning of the video, such as audio failure, a neighboring session number was being 
transcribed and rated instead. Twenty-two sessions were substituted. Session length slightly 
varied (Mean = 62.1 min, SD = 7.69 min). Reliability coefficients were established on 20% (n 
= 36 sessions) of the ratings. The intraclass correlation coefficients ranged from ICC(2,1) = 
.46 to .86 (Mean = .72). This indicated acceptable to good agreement (Shrout, 1998).  
 Beck Depression Inventory. The revised version of the Beck Depression Inventory 
(BDI-II; Hautzinger, Keller, & Kühner, 2006) is a self-assessment tool consisting of 21 items 
to determine depressive symptoms during the past two weeks. The BDI-II is not only an 
indicator of the severity of depressive symptoms in accordance with DSM-IV but also one of 
the most widely used self-report measures for depression in clinical practice and research 
(Kühner, Bürger, Keller, & Hautzinger, 2007). It has shown robust psychometric properties 
(Hautzinger et al., 2006). 
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 Beck Anxiety Inventory. The Beck Anxiety Inventory (BAI; Margraf, Beck, & Ehlers, 
2007) is a self-report questionnaire to detect the severity of anxiety symptoms. The BAI 
consists of 21 descriptive statements with regard to somatic and cognitive symptoms of 
anxiety during the last seven days. The BAI can be cited as a reliable and valid questionnaire 
(Margraf et al., 2007). 
Procedure 
In this study, patients were treated with an integrative form of CBT. The duration of 
the treatment was predefined by the RCT and based on the usual length of cognitive-
behavioral therapies in the given outpatient setting, i.e., 25 ± 3 sessions of 50 minutes each. 
All therapy sessions were video recorded for quality assurance, research and supervision 
purposes. Four sessions per therapy (1, 8, 16 and 24) were transcribed and subsequently rated 
for defense mechanisms. Symptom severity as measured with the BDI-II and BAI was 
assessed at the same four measurement points. 
Analytic strategy 
All data analyses were done using the international scientific software HLM 7 
(Raudenbush, Brok, & Congdon, 2011). For data analysis, we used hierarchical linear models 
(HLM; Raudenbush & Bryk, 2002; see Appenix A for equations of the HLM and detailed 
description). These models address the dependency of the data presented in longitudinal 
studies, due to the repeated measures (here, assessment of all measurements in therapy 
sessions 1, 8, 16, and 24) nested within patients. Besides providing a more robust estimation 
of change than classical parametric statistics, HLM has other strengths like handling missing 
data mimicking an intent-to-treat approach by including all participants into the analysis who 
completed outcome measures at least once. 
We first ran two-level fully unconditional models with BAI and BDI as outcome 
variables. Based on these two unconditional models we calculated intraclass correlation 
coefficients to establish the variance explained by patient effects (level 2). In the BAI 
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unconditional model this was ICC=0.41, in the BDI unconditional model ICC=0.52, meaning 
that 41% of the variance of the BAI and 52% of the variance of the BDI is explained by 
patient effects, indicating that HLM is necessary. Then, two conditional models (one for each 
outcome variable) were calculated including ODF as a predictor and disaggregating its 
within- and between-patient effects (Falkenström et al., 2017). In these models, ODF was 
included as a level 1 predictor patient-mean centered, capturing the within-patient effect of 
ODF on the outcome variables. At the same time, the patient’s average level of ODF during 
treatment (grand-mean centered) was included as a level 2 predictor of the intercept 
(estimated value of the outcome variable on a session where the patients have an average 
ODF), capturing the between-patient effect. The level of ODF during treatment was also 
included (grand-mean centered) as a level 2 predictor of the ODF within-patient effect, to test 
if there was variability based on the patients’ ODF-level during therapy.  
In a second set of analysis, we ran two-level models including the frequency of (i) 
adaptive, (ii) neurotic, and (iii) immature defenses as predictors of the outcome variables. The 
frequencies of the three defense categories were included in the same model person-mean 
centered. This model allows disaggregating the within-patient effects of each category, 
controlling for the within-patient effects of the other ones. Furthermore, the frequency of the 
three variables (grand-mean centered) was included as level 2 predictors of the intercept, 
disentangling the between-patient effect of each type of defense when controlling for the 
effect of the other ones. Finally, the frequency of the three types of defenses was included 
(again, grand-mean centered) as predictors of the within-patient effects of each of the three 
defense categories. 
For the significant effects we calculated effect sizes by computing pseudo R2. To 
compute this indicator of the size of the effects we subtracted the variance explained by the 
conditional models (i.e., the one including the targeted predictor) from the variance explained 
by the unconditional model (i.e., the one not including the predictor) and divided it by the 
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variance explained by the unconditional model. Thus, pseudo R2 is to be interpreted as the 
percentage of outcome variance explained by the predictor. 
Figures of the BDI and BAI session effects (Appendix B) were produced using R (R 
Core Team, 2017) and the packages lme4 (Bates, Meachler, Bolker, & Walker, 2015) and 
ggeffects (Lüdecke, 2018). 
Results 
ODF as a predictor of treatment outcome 
The results of the HLM analyses with ODF as predictor of treatment outcome showed 
that there was a significant between-patient effect of ODF on symptom severity of depression 
as measured with the BDI, fixed effect(γ01) = -7.51, SE = 1.62, CI95 [-10.69, -4.33], t(44) = -
4.63, p < .001, pseudo R2= .38. Patients with one ODF score unit above the mean across 
treatment have 7.51 units less in the BDI during treatment. Furthermore, the within-patient 
effect of ODF on BDI approached significance, fixed effect(γ10) = -2.43, SE = 1.23, CI95 [-
4.84, -0.02], t(44) = -1.98, p = .054. Again, a one-unit variance in patient’s ODF from the 
individual mean was associated with a 2.43 points lower score in the BDI at that session. With 
regard to random effects on level 2, patients significantly varied in their BDI scores when 
having their average level of ODF during treatment (VARu0 = 34.31, χ2(42)=173, p < .001) 
and depending on ODF fluctuations during treatment (VARu1 = 13.59, χ2(42)=62, p = .03). 
When analyzing the effects of ODF on symptom severity of anxiety as assessed with the BAI, 
we also found a significant between-patient effect, fixed effect(γ01) = -5.50, SE = 1.53, CI95 [-
8.50, -2.50], t(44) = -3.59, p < .001, pseudo R2= .33. Patients with an ODF-level one-unit 
above the mean during treatment tend to have 5.50 units less in the BAI during treatment. 
However, the within-patient effect of ODF on BAI was not significant, fixed effect(γ10) = -
1.66, SE = 1.10, CI95 [-3.82, 0.50], t(44) = -1.51, p = .14. Random effects on level 2 showed 
that patients varied significantly in their BAI scores when having their average level of ODF 
during treatment (VARu0 = 26.04, χ2(42)=112, p < .001) but not significantly depending on 
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ODF fluctuations during treatment (VARu1 = 0.09, χ2(42)=55, p = .09). For overall effects of 
sessions on symptomatology (BDI, BAI) see Appendix B. 
Insert Table 1 here 
Adaptive, neurotic and immature defenses as a predictor of therapy outcome 
The calculated models estimated the effects of the different defense categories and 
presented a significant between-patient effect of adaptive defenses on symptom severity of 
depression, fixed effect(γ01) = -0.49, SE = 1.16, CI95 [-2.76, 1.78], t(42) = -3.04, p = .004. 
pseudo R2= .21. A one-unit greater frequency of adaptive defenses across treatment, was 
associated with 0.49 points less on the BDI during therapy. However, there was no significant 
between-patient effect of adaptive defenses on severity of anxiety, fixed effect(γ01)= -0.02, SE 
= 0.14, CI95 [-0.29, 0.25], t(42) = -0.12, p = .90. Furthermore, when controlling for the effect 
of the other defense categories, a significant within-patient effect of adaptive defenses on 
depression severity was shown, fixed effect(γ10) = -0.35, SE = 0.16, CI95 [-0.66, -0.04], t(42) = 
-2.27, p = .03, pseudo R2= .19, but not on anxiety severity, fixed effect(γ10) = -0.21, SE = 
0.18, CI95 [-0.56, 0.14], t(42) = -1.19, p = .24. A one-unit increase in the frequency of 
adaptive defenses was associated with 0.35 units reduction of depression severity.  
The frequency of neurotic defenses over the course of treatment was neither 
significantly associated with depression severity, fixed effect(γ02) = -0.10, SE = 0.26, CI95 [-
0.61, 0.41], t(42) = -0.40, p = .70, nor anxiety severity, fixed effect(γ02) = 0.24, SE = 0.23, 
CI95 [-0.21, 0.69], t(42) = 1.03, p = .31, during treatment. Also, there was no significant 
within-patient effect of neurotic defenses on depression severity, fixed effect(γ20) = 0.24, SE = 
0.14, CI95 [-0.03, 0.51], t(42) = 1.68, p = .10. However, the within-patient effect of neurotic 
defense on anxiety severity was significant, fixed effect(γ20) = 0.37, SE = 0.15, CI95 [0.08, 
0.66], t(42) = 2.522, p = .02, pseudo R2= .08. A one-unit increase in neurotic defense 
frequency was associated with a 0.37 increase in anxiety severity. 
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The immature defenses exhibited significant between-patient effects on both 
depression severity, fixed effect(γ03) = 0.40, SE = 0.17, CI95 [0.07, 0.73], t(42) = 2.42, p = .02, 
pseudo R2= .14, and anxiety severity, fixed effect(γ03) = 0.52, SE = 0.15, CI95 [0.23, 0.81], 
t(42) = 3.53, p = .001, pseudo R2= .26. A one-unit greater frequency of immature defenses 
across treatment, was related to 0.40 units greater depressive severity and a 0.52 units greater 
anxiety severity during therapy. Additionally, there was a significant within-patient effect of 
the immature defenses on depressive severity, fixed effect(γ30) = 0.34, SE = 0.17, CI95 [0.01, 
0.67], t(42) = 2.01, p = . 05, pseudo R2= .24, and anxiety severity, fixed effect(γ30) = 0.38, SE 
= 0.15, CI95 [0.09, 0.67], t(42) = 2.50, p = . 02, pseudo R2= .23. A one-unit increase of the 
frequency of immature defenses was associated with a 0.34 units increase of depression 
severity and a 0.38 units increase of anxiety severity. 
Here, random effects on level 2 represent the variability around the estimated value of 
BDI (VARu0 = 42.50, χ2(26)=187, p < .001) and BAI (VARu0 = 32.26, χ2(26)=149, p < .001) 
when patients have their average adaptive, neurotic, and immature defenses. Both were 
significant. Further, patients significantly varied in their BAI scores depending on the 
fluctuations in adaptive (VARu1 = 0.39, χ2(26)=66, p < .001), neurotic (VARu2 = 0.02, 
χ2(26)=49, p < .01), and maladaptive (VARu3 = 0.10, χ2(26)=54, p < .001) defenses. Not so in 
their BDI values (VARu1 = 0.13, χ2(26)=37, p = .07; VARu2 = 0.02, χ2(26)=27, p = .4; VARu3 
= 0.20, χ2(26)=28, p = .34). Further, see Appendix C for random effects graphed for randomly 
chosen individual patients. 
Insert Table 2 here 
Discussion 
The present study aimed to analyze the effects of defensive functioning on 
psychotherapy outcome during acute treatment using longitudinal models and to disaggregate 
the within- and between-patient effects of this predictor. 
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In line with our first hypothesis and with previous research (e.g., DeFife & Hilsenroth, 
2005), ODF exhibited a large between-patient effect on symptoms of depression, explaining 
38% of variance in the estimated value for an average patient. As expected, a higher number 
of adaptive defense mechanisms was associated with less severe depressive symptoms during 
treatment while a higher number of immature defenses was related to more severe depressive 
symptoms. The second hypothesis was largely, but not completely upheld. ODF and 
maladaptive defenses displayed a significant between-patient effect on anxiety symptoms, 
with ODF explaining 33% of outcome variance and maladaptive defenses explaining 26%, 
while neurotic defenses did not. This pattern was also found by Euler et al. (2018) and Perry 
(2001) who reported a significant change on the level of maladaptive defenses first. One 
possible explanation as put forward by Vaillant (1993) is that defenses change up the 
hierarchy in a stepwise fashion with maladaptive defenses moving up to neurotic and 
eventually adaptive defenses. On the contrary, other studies did not confirm such stepwise 
changes (Albucher, Abelson, & Nesse, 1998; Akkermann et al., 1999; Babl et al., 2019). Our 
third hypothesis was upheld: the within-patient effect of ODF, adaptive and maladaptive 
defenses on symptom severity of depression reached the significance level, indicating that an 
increase in adaptive defenses and a decrease in maladaptive defenses over the course of 
psychotherapy is accompanied by an improvement in depressive symptoms. Together with the 
evidence presented by former trials (e.g. Heldt et al., 2007; Kramer et al., 2012), it can be 
concluded with some confidence that not only differences in defensive functioning between 
patients but also differences within patients over time are potent predictors of therapy 
outcome at the symptomatic level. The fourth hypothesis addressed within-patient effects of 
defenses on anxiety symptoms and was partially upheld. The within-patient effect of ODF on 
the severity of anxiety symptoms was non-significant. This may be due to the different nature 
of anxiety and depressive disorders. Previously, depression has been referred to as a state, 
while anxiety has been discussed as a trait (Bond & Perry, 2004; Perry, 2001). In general, 
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traits are more enduring, while states change with respect to internal and external stimuli 
(Bond & Perry, 2004). Our findings support this notion. However, when looking more 
specifically at defense categories, the within-patient effect of neurotic and immature defenses 
on anxiety severity was significant, explaining 8% of variance in the BAI score in the case of 
the former, and 23% in the case of the latter. 
In line with previous research, our study confirmed defensive functioning not only as a 
significant between- but also within-patient predictor of therapy outcome. One might, 
therefore wonder how such improvements of defensive functioning in individual patients over 
time can be fostered. Preliminary evidence suggests that the process of addressing defenses is 
related to improvements in ODF (Olsen, Perry, Janzen, Petraglia, & Presniak, 2011), neurotic 
(Winston, Samstag, Winston, & Muran, 1994), maladaptive defenses (Hersoug et al., 2005), 
and overall therapy outcome (Perry, Petraglia, Olson, Presniak, & Metzger, 2012). 
Psychoanalytic and dynamic therapy specifically addresses defenses in-session aiming to 
develop more adaptive defensive functioning. However, even therapeutic approaches not 
aiming at changing defensive functioning, as the integrative interventions applied in this 
study, seem to exhibit a favorable effect on defenses (Babl et al., 2019). This indicates that 
despite their psychodynamic roots, defenses can be applied as trans-theoretical constructs, 
suggesting that knowledge about a patient’s predominant defense mechanisms could be 
helpful to therapists of all orientations. By this, knowledge about individual defenses may 
contribute to a better understanding of the patients’ psychological functioning and thus 
increase therapists’ responsiveness. Working with defenses may generally play an important 
role in treatment, which warrants further study. Future studies that examine the processes 
leading to improved defensive functioning are likely to inform good clinical practice. 
The results of our study need to be interpreted in light of several potential limitations. 
First, while the sample size was limited, modeling data from multiple assessment times 
resulted in fairly precise and significant measurements of change. Second, the subjects in our 
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study were diagnosed with depression, anxiety- and adjustment disorders, treated in an 
outpatient setting. Therefore, the generalizability of our results to more severely impaired 
patients or patients in an inpatient setting is uncertain. Furthermore, our sample was too small 
to calculate subgroup analyses based on diagnoses, thus disregarding possible differential 
effects. Hereby, we refer to previous studies that have investigated defensive functioning for 
the distinct diagnostic groups of depressive (Bond & Perry, 2004; Perry & Bond, 2009), 
anxiety- (Kipper et al., 2005; Heldt et al., 2007), and adjustment disorders (Doruk, Sütcigil, 
Erdem, Isintas, & Özgen, 2009). Third, the direction of causal influences between change in 
defenses and change in symptoms could not be determined. Last, our study did not address 
the relationship between defenses and other important factors in psychotherapy, such as the 
therapeutic alliance, interpersonal problems, personality pathology and recovery. 
The novel contributions of our study are twofold. First, we measured the effects of 
defensive functioning and changes thereof on psychotherapy outcome using longitudinal 
analyses. Compared to previous research in the field with two measuring points per patient, 
we had four assessment times of both defenses as well as symptoms of anxiety and 
depression. Thus, we were able to apply mixed models and to estimate the random effects of 
defenses on treatment outcome (Raudenbush & Bryk, 2002). In doing so, we were able to deal 
with the dependency of the observations (i.e., correlations of the residuals), accounting for the 
variability of defense effects among patients and estimating the effects for each individual 
patient. Second, to our knowledge, this is the first study that calculates both within- and 
between patient effects of defensive functioning on symptom severity of depression and 
anxiety in the same model, thus controlling for the effect of the respective other (i.e., hybrid 
random effects models; Falkenström et al., 2017). These procedures allow for a robust and 
unbiased estimation of the parameters and could build a basis for future studies aiming to 
measure defensive functioning longitudinally. 
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In conclusion, two main findings emerge from our study. The first is that overall 
defensive functioning (ODF) exhibited a significant between-patient effect on both depressive 
and anxiety symptoms. The second main finding concerns a differential prediction of changes 
in anxiety and depressive symptoms by defenses, i.e., an increase in adaptive and a decrease 
in immature defenses over the course of treatment (within-patient effects) predicted symptom 
reduction of depression whereas a decrease in neurotic and immature defenses was associated 
with reductions in anxiety symptoms. 
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Table 1.    
Models with ODF as predictor    
 Severity level  Within-patient ODF effect 
Fixed Model Effects γ SE  γ SE 
BDI models      
Unconditional model      
Intercept 13.97*** 1.22    
Main effect model       
Intercept 13.78*** 1.01  -2.43* 1.23 
Btw ODF   -7.51*** 1.62  -0.59 1.69 
Model comparison Δ χ2(5) = 24.66, p < .001 
BAI models      
Unconditional model      
Intercept 12.04*** 1.09    
Main effect model       
Intercept 11.84*** 0.95  -1.66 1.10 
Btw ODF   -5.50*** 1.53  0.003 1.38 
Model comparison Δ χ2(5) = 13.74, p = .02 
Note.      
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Table 2. 
Models with defense categories as predictors 
  
Severity level  
Within-patient 
Adaptative Def. 
effect 
 
Within-patient 
Neurotic Def. 
effect 
 
Within-patient 
Immature Def. 
effect 
Fixed Model Effects  γ SE  γ SE  γ SE  γ SE 
BDI model            
Unconditional Model            
Intercept  13.97*** 1.22          
Main Effects Model            
Intercept  13.83*** 1.07  -0.35* 0.16  0.24 0.14  0.34* 0.17 
Adaptative Def.  -0.49** 0.16  0.03 0.02  0.01 0.02  -0.02 0.02 
Neurotic Def.  -0.10 0.25  0.08 0.04  0.01 0.03  0.04 0.05 
Immature Def.  0.40* 0.17  -0.02 0.02  0.01 0.02  -0.03 0.03 
Model comparison Δ χ2(24) = 35.30, p =.06 
BAI model             
Unconditional Model            
Intercept  12.04*** 1.09          
Interactional Model            
Intercept  12.01*** 0.96  -0.21 0.18  0.37* 0.15  0.38* 0.15 
Adaptative Def.  -0.02 0.14  0.03 0.03  0.04* 0.02  -0.02 0.02 
Neurotic Def.  0.24 0.23  0.08 0.04  0.02 0.03  -0.01 0.01 
Immature Def.  0.52*** 0.15  -0.02 0.02  0.02 0.02  0.001 0.03 
Model comparison Δ χ2(24) = 45.02, p =.006 
Note. *** p < .001, ** p < .01, * p ≤  .05 
 
 
 
